Small Cell Lung Cancer
Showing NaN - NaN of 33
Small Cell Lung Cancer Trial in Worldwide (biological, drug, radiation)
Recruiting
- Small Cell Lung Cancer
- Pembrolizumab 200 mg
- +8 more
-
Chandler, Arizona
- +170 more
Feb 2, 2023
Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab, MK-4830, MK-5890)
Recruiting
- Small Cell Lung Cancer
- Pembrolizumab
- +6 more
-
Gilbert, Arizona
- +48 more
Jan 19, 2023
Small Cell Lung Cancer Trial in Worldwide (Tiragolumab, Atezolizumab, Carboplatin)
Active, not recruiting
- Small Cell Lung Cancer
- Tiragolumab
- +4 more
-
Lone Tree, Colorado
- +123 more
Dec 21, 2022
Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)
Recruiting
- Small Cell Lung Cancer
- +8 more
- ladiratuzumab vedotin
- pembrolizumab
-
Chandler, Arizona
- +65 more
Dec 19, 2022
Small Cell Lung Cancer Trial in Worldwide (Irinotecan liposome injection, Topotecan)
Active, not recruiting
- Small Cell Lung Cancer
- Irinotecan liposome injection
- Topotecan
-
Denver, Colorado
- +117 more
Nov 22, 2022
Small Cell Lung Cancer Trial in Seoul (Durvalumab)
Active, not recruiting
- Small Cell Lung Cancer
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +1 more
Nov 6, 2022
Small Cell Lung Cancer Trial in Worldwide (BMS-986012 (anti-fucosyl-GM1), Nivolumab)
Active, not recruiting
- Small Cell Lung Cancer
- BMS-986012 (anti-fucosyl-GM1)
- Nivolumab
-
New York, New York
- +15 more
Sep 28, 2022
Small Cell Lung Cancer Trial in Worldwide (Venetoclax, Atezolizumab, Carboplatin)
Advanced Solid Tumours, Small Cell Lung Cancer Trial in Australia, Korea, Republic of, Taiwan (IMP4297)
Recruiting
- Advanced Solid Tumours
- Small Cell Lung Cancer
-
Albury, New South Wales, Australia
- +12 more
Aug 10, 2021
Small Cell Lung Cancer Trial in Worldwide (LY3295668 Erbumine)
Completed
- Small Cell Lung Cancer
- LY3295668 Erbumine
-
Fayetteville, Arkansas
- +39 more
Jul 30, 2021
Small Cell Lung Cancer Trial in Worldwide (Placebo for dexamethasone, Placebo for rovalpituzumab tesirine, Rovalpituzumab
Terminated
- Small Cell Lung Cancer
- Placebo for dexamethasone
- +3 more
-
Huntsville, Alabama
- +307 more
Jul 28, 2021
Small Cell Lung Cancer Trial in Seoul (AZD1775)
Completed
- Small Cell Lung Cancer
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 18, 2021
Small Cell Lung Cancer Trial in Worldwide (Rovalpituzumab tesirine, Topotecan, Dexamethasone)
Completed
- Small Cell Lung Cancer
- Rovalpituzumab tesirine
- +2 more
-
Huntsville, Alabama
- +194 more
Feb 19, 2021
Small Cell Lung Cancer Trial in Seoul (Olaparib)
Completed
- Small Cell Lung Cancer
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 16, 2021
Small Cell Lung Cancer Trial in Worldwide (Dinutuximab, Irinotecan, Topotecan)
Completed
- Small Cell Lung Cancer
- Dinutuximab
- +2 more
-
Anchorage, Alaska
- +225 more
Nov 12, 2020
Small Cell Lung Cancer Trial in Worldwide (Veliparib, Carboplatin, Etoposide)
Small Cell Lung Cancer Trial in Worldwide (Prexasertib)
Completed
- Small Cell Lung Cancer
-
Fayetteville, Arkansas
- +40 more
Mar 12, 2020
Small Cell Lung Cancer Trial in Seoul (Durvalumab)
Unknown status
- Small Cell Lung Cancer
-
Seoul, MA, Korea, Republic ofSamsung Medical Center
Feb 27, 2020
Small Cell Lung Cancer Trial in Seoul (pembrolizumab, paclitaxel)
Completed
- Small Cell Lung Cancer
- pembrolizumab, paclitaxel
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 7, 2020
Small Cell Lung Cancer Trial in Korea, Republic of, Romania, United States (LY2523355, Granulocyte colony-stimulating factor
Completed
- Small Cell Lung Cancer
- LY2523355
- Granulocyte colony-stimulating factor (G-CSF)
-
Torrington, Connecticut
- +10 more
Sep 9, 2019
Advanced Solid Tumors, Ovarian Cancer, Small Cell Lung Cancer Trial in Chiba, Shizuoka, Seoul (Alisertib, Paclitaxel)
Terminated
- Advanced Solid Tumors
- +2 more
-
Chiba, Japan
- +2 more
Jun 11, 2019
Small Cell Lung Cancer Trial in Seoul (AZD2811)
Terminated
- Small Cell Lung Cancer
-
Seoul, Korea, Republic ofSamsung Medical center
Nov 23, 2018